Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication

World Journal of Gastroenterology

Volumn 11, Issue 7, 2005, Pages 1048-1051

  Chang, Full Young ^a   Chen, Chih Yen ^a   Lu, Ching Liang ^a   Luo, Jiing Chyuan ^a   Lu, Rei Hwa ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Duodenal ulcer; Endothelin 1; Helicobacter pylori; Nitric oxide

Indexed keywords

AMOXICILLIN; ENDOTHELIN 1; METRONIDAZOLE; NITRIC OXIDE; RABEPRAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BLOOD SAMPLING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG RESPONSE; DUODENUM ULCER; ENZYME IMMUNOASSAY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULCER HEALING;

EID: 14844326276     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i7.1048     Document Type: Article

References (31)

1. Soll AH. Peptic ulcer and its complications. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Feldman M, Scharschmidt BF and Sleisenger MH, eds. 6th ed. Philadelphia: WB Saunders 1998: 620-678
2. Cho CH, Koo MW, Garg GP, Ogle CW. Stress-induced gastric ulceration: Its etiology and clinical implication. Scand J Gastroenterol 1992; 27: 257-262
3. Kamada T, Kawano S, Sato N, Fukuda M, Fusamoto H, Abe H. Gastric mucosal blood distribution and its changes in the healing process of gastric ulcer. Gastroenterology 1983: 84: 1541-1546
4. Yanagisawa M. The endothelin system: A new target for therapeutic intervention. Circulation 1994; 89: 1320-1322
5. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
6. Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999; 353: 133-138
7. Lazarotos S, Kashimura H, Nakahara A, Fukutomi H, Osuga T, Urushidani T, Miyauchi T, Goto K. Gastric ulcer induced by submucosal injection of ET-1: Role of potent vasoconstriction and intraluminal acid. Am J Physiol 1993; 265(3 Pt 1): G491-498
8. Masuda E, Kawano S, Michida T, Tsuji S, Nagano K, Fusamoto H, Kamada T. Plasma and gastric mucosal endothelin-1 concentrations in patients with peptic ulcer. Dig Dis Sci 1997; 42: 314-318
9. Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004; 126: 903-913
10. Pique JM, Whittle BJ, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989; 174: 293-296
11. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-1949
12. Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton SJ. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol 2001; 54: 293-297
13. Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori A broad data review. Helicobacter 2003; 8: 95-104
14. Lehmann FS, Stalder GA. Hypotheses on the role of cytokines in peptic ulcer disease. Eur J Clin Invest 1998; 28: 511-519
15. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
16. Chen CY, Lu CL, Chang FY, Lu RH, Ng WW, Lee SD. Endothelin-1 is a candidate mediating intestinal dysmotility in patients with acute pancreatitis. Dig Dis Sci 1999: 44: 922-926
17. Unge P, Berstad A. Pooled analysis of Helicobacter pylori treatment regimens. Scand J Gastroenterol 1996; 31 Suppl 220): 27-40
18. van der Hulst RW, Keller JJ, Rauws EA, Tytgat GN. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996; 1: 6-19
19. Chang FY, Lu CL, Chen CY, Luo JC, Kang LJ, Lee SD. The effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients of active duodenal ulcer. J Gastroenterol Hepatol 2003; 18: 1250-1256
20. Bobrzynski A. Hormonal, secretory and morphological alterations in gastric mucosa in the course of Helicobacter pylori eradication in patients with duodenal ulcer and non-ulcer dyspepsia. J Physiol Pharmacol 1997; 48(Suppl 3): 1-56
21. Hahm KB, Lee KJ, Kim YS, Kim JH, Cho SW, Yim H, Joo HJ. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. Dig Dis Sci 1998; 43: 235-240
22. Chen TS, Tsay SH, Chang FY, Lee SD. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: A 12-mo.follow-up study. Am J Gastroenterol 1994; 89: 1511-1514
23. Michida T, Kawano S, Masuda E, Kobayashi I, Nishimura Y, Tsujii M, Hayashi N, Takei Y, Tsuji S, Nagano K, Fusamoto H, Kamada T. Role of enothelin 1 in hemorrhagic shock-induced gastric mucosal injury in rats. Gastroenterology 1994; 106: 988-993
24. Said SA, El Mowafy AM. Role of endogenous endothelin-1 in stress-induced gastric mucosal damage and acid secretion in rats. Regul Pept 1998; 73: 43-50
25. Akimoto M, Hashimoto H, Shigemoto M, Yokoyama I. Relationship between recurrence of gastric ulcer and the microcirculation. J Cardiovasc Pharmacol 1998; 31(Suppl 1): S507-508
26. Mori S, Kaneko H, Mitsuma T, Hayakawa T, Yamaguchi C, Uruma M. Implications of gastric topical bioactive peptides in ammonia-induced acute gastric mucosal lesions in rats. Scand J Gastroenterol 1998, 33: 386-393
27. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-1949
28. Nishida K, Ohta Y, Ishiguro I. Changes in nitric oxide production with lesion development in the gastric mucosa of rats with water immersion restraint stress. Res Commun Mol Pathol Pharmacol 1998; 100: 201-212
29. Stachura J, Konturek JW, Karczewska A, Domschke W, Popiela T, Konturek SJ. Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactavity in vivo and in vitro. J Physiol Pharmacol 1996; 47: 131-135
30. Hogan DL, Rapier RC, Dreilinger A, Koss MA, Basuk PM, Weinstein WM, Nyberg LM, Isenberg JI. Duodenal bicarbonate secretion: Eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110: 705-716
31. Fandriks L, von Bothmer C, Johansson B, Holm M, Bolin I, Pettersson A. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology 1997; 113: 1570-1575